NTI 5.33% 7.1¢ neurotech international limited

Ann: NTI to Present at Rett Syndrome Foundation Meeting, page-2

  1. 13,006 Posts.
    lightbulb Created with Sketch. 776
    Regarding Rett Syndrome: I just wonder why NTI would bother to pursue anything in respect to Rett Syndrome - when another Australian company (NEU.AX) and their American partner already have now successfully launched an FDA APPROVED product into the all-important US market?

    wasa

    PS: You can look up the relevant discussion on the NEU HC board.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.004(5.33%)
Mkt cap ! $72.23M
Open High Low Value Volume
7.5¢ 7.5¢ 7.1¢ $41.31K 571.2K

Buyers (Bids)

No. Vol. Price($)
4 212673 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 76821 1
View Market Depth
Last trade - 14.01pm 16/08/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.